Reflecting on a milestone year for cell and gene therapies
With the first therapies approved for solid tumors and new breakthroughs in diabetes treatments, the last year been notable in advancing cell and gene therapies.
In Association With Terumo Blood and Cell Technologies
With the first therapies approved for solid tumors and new breakthroughs in diabetes treatments, the last year been notable in advancing cell and gene therapies.
Give your business an edge with our leading industry insights.